1017 related articles for article (PubMed ID: 17510415)
1. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
2. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
3. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
Lee SB; Oh HK; Kim HK; Joe YA
Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
[TBL] [Abstract][Full Text] [Related]
4. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
5. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
6. Interferon-β efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis.
Xiao HB; Zhou WY; Chen XF; Mei J; Lv ZW; Ding FB; Li GQ; Zhong H; Bao CR
Gene Ther; 2012 Oct; 19(10):1030-4. PubMed ID: 22071966
[TBL] [Abstract][Full Text] [Related]
7. Potent anti-tumor and prolonged survival effects of E. coli-derived non-glycosylated kringle domain of tissue-type plasminogen activator.
Kang BH; Shim BS; Lee SY; Lee SK; Hong YK; Joe YA
Int J Oncol; 2006 Feb; 28(2):361-7. PubMed ID: 16391790
[TBL] [Abstract][Full Text] [Related]
8. The kringle domain of tissue-type plasminogen activator inhibits in vivo tumor growth.
Shim BS; Kang BH; Hong YK; Kim HK; Lee IH; Lee SY; Lee YJ; Lee SK; Joe YA
Biochem Biophys Res Commun; 2005 Feb; 327(4):1155-62. PubMed ID: 15652516
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
10. The kringle domain of tissue-type plasminogen activator inhibits extracellular matrix-induced adhesion and migration of endothelial cells.
Lee BH; Kim HK; Joe YA
Biosci Biotechnol Biochem; 2008 Sep; 72(9):2303-8. PubMed ID: 18776698
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature.
Le Ricousse-Roussanne S; Barateau V; Contreres JO; Boval B; Kraus-Berthier L; Tobelem G
Cardiovasc Res; 2004 Apr; 62(1):176-84. PubMed ID: 15023564
[TBL] [Abstract][Full Text] [Related]
12. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
Kim HK; Joe YA
Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps.
Yi C; Xia W; Zheng Y; Zhang L; Shu M; Liang J; Han Y; Guo S
J Surg Res; 2006 Sep; 135(1):100-6. PubMed ID: 16566941
[TBL] [Abstract][Full Text] [Related]
14. Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms.
Nishiwaki Y; Yoshida M; Iwaguro H; Masuda H; Nitta N; Asahara T; Isobe M
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):512-8. PubMed ID: 17170379
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
16. Decorin suppresses tumor cell-mediated angiogenesis.
Grant DS; Yenisey C; Rose RW; Tootell M; Santra M; Iozzo RV
Oncogene; 2002 Jul; 21(31):4765-77. PubMed ID: 12101415
[TBL] [Abstract][Full Text] [Related]
17. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells.
Shmilovich H; Ben-Shoshan J; Tal R; Afek A; Barshack I; Maysel-Auslander S; Harats D; Keren G; George J
Tissue Eng Part A; 2009 Sep; 15(9):2741-9. PubMed ID: 19275472
[TBL] [Abstract][Full Text] [Related]
19. The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma growth.
Kim CK; Hong SH; Joe YA; Shim BS; Lee SK; Hong YK
Cancer Sci; 2007 Feb; 98(2):253-8. PubMed ID: 17233842
[TBL] [Abstract][Full Text] [Related]
20. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
